Whittier Trust Co. of Nevada Inc. Has $1.08 Million Position in Relx Plc $RELX

Key Points

• Whittier Trust Co. of Nevada Inc. increased its stake in Relx Plc by 54.8%, owning 19,941 shares valued at approximately $1.08 million at the end of the recent quarter.
• Relx has notable institutional investment interest, with 15.02% of its stock held by institutional investors and multiple firms increasing their positions in the company recently.
• Analyst ratings for Relx have been mixed, with one upgrade to a "strong-buy" rating, while others have moved to a "hold" rating, reflecting diverse opinions on the stock's performance potential.

Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Relx Plc (NYSE:RELX - Free Report) by 54.8% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,941 shares of the technology company's stock after purchasing an additional 7,057 shares during the quarter. Whittier Trust Co. of Nevada Inc.'s holdings in Relx were worth $1,084,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in RELX. GAMMA Investing LLC boosted its position in Relx by 23.5% during the first quarter. GAMMA Investing LLC now owns 13,471 shares of the technology company's stock worth $679,000 after purchasing an additional 2,563 shares during the period. Cambridge Investment Research Advisors Inc. boosted its position in shares of Relx by 19.5% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 18,957 shares of the technology company's stock valued at $956,000 after acquiring an additional 3,092 shares during the period. Golden State Wealth Management LLC boosted its position in shares of Relx by 100.0% in the first quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company's stock valued at $30,000 after acquiring an additional 294 shares during the period. PDS Planning Inc lifted its position in Relx by 10.1% in the first quarter. PDS Planning Inc now owns 8,475 shares of the technology company's stock worth $427,000 after purchasing an additional 775 shares during the period. Finally, Money Concepts Capital Corp lifted its position in Relx by 237.4% in the first quarter. Money Concepts Capital Corp now owns 15,604 shares of the technology company's stock worth $787,000 after purchasing an additional 10,979 shares during the period. Institutional investors own 15.02% of the company's stock.

Relx Price Performance

Relx stock opened at $46.83 on Thursday. The firm has a market capitalization of $85.57 billion, a P/E ratio of 25.18, a PEG ratio of 3.04 and a beta of 0.87. Relx Plc has a 1 year low of $44.19 and a 1 year high of $56.33. The business has a 50-day moving average of $46.68 and a 200-day moving average of $50.55. The company has a current ratio of 0.47, a quick ratio of 0.42 and a debt-to-equity ratio of 2.55.

Analyst Ratings Changes

Several research analysts recently commented on RELX shares. Weiss Ratings reaffirmed a "buy (b)" rating on shares of Relx in a research report on Wednesday, October 8th. Wall Street Zen lowered Relx from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Kepler Capital Markets upgraded Relx from a "hold" rating to a "strong-buy" rating in a research note on Thursday, September 18th. Morgan Stanley restated an "overweight" rating on shares of Relx in a research note on Thursday, September 11th. Finally, Barclays restated an "overweight" rating on shares of Relx in a research note on Tuesday, October 7th. One investment analyst has rated the stock with a Strong Buy rating and five have given a Buy rating to the stock. According to data from MarketBeat.com, Relx presently has an average rating of "Buy".

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.